Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene (ENSG00000225806) encodes a putative long non-coding RNA that is transcribed antisense to the GNAS locus[4]. Antisense transcripts in general can regulate the sense gene at the level of transcription, RNA processing, mRNA stability, or translation, often via RNA masking, interference, or RNAi-related mechanisms[1]. The GNAS locus encodes the alpha subunit of the stimulatory G protein (Gsα), which is associated with critical endocrine regulatory pathways. While the antisense RNA at this locus may participate in imprinting regulation or gene silencing, there is no evidence that ENSG00000225806 itself is a therapeutic target, or that it encodes a receptor, enzyme, or other conventional druggable protein[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to GNAS.